Shivalik Rasayan Limited has scheduled its Extra-Ordinary General Meeting (EGM) for Thursday, August 20, 2026, to transact business as set out in the notice. The meeting will be conducted through Video Conferencing (VC) or Other Audio Visual Means (OAVM) starting at 1:00 PM IST from Hotel Saffron Leaf, GMS Road, Dehradun, Uttarakhand. This procedural step ensures shareholder approval for specific corporate actions pending before the Board.

The company notified shareholders via email on July 24, 2026, while physical notices were dispatched on July 27, 2026. In compliance with Section 108 of the Companies Act, 2013, Rule 20 of the Companies (Management and Administration) Rules, 2014, and Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the firm engaged Central Depository Services (India) Limited (CDSL) as the agency for providing e-voting facilities.

Shareholders are required to register or update their email addresses to participate. Those holding shares in physical mode must submit requests with their Name, Folio Number, complete address, and self-attested PAN Card to cs@shivalikrasayan.com or beetalrta@gmail.com . Demat account holders should update details directly with their Depository Participants. The cut-off date for entitlement to vote is August 13, 2026.

Remote e-voting allows members to cast votes electronically before the meeting. The facility operates within a strict window, ensuring timely aggregation of shareholder sentiments. Members who have already voted remotely may attend the EGM but cannot vote again during the session.

E-Voting Schedule

Any person acquiring shares after the notice dispatch but holding them on the cut-off date can obtain User ID and password by emailing helpdesk.evoting@cdslindia.com with DP ID and Client ID/Folio Number. Queries regarding the CDSL e-Voting System can be directed to helpdesk.evoting@cdslindia.com or via phone at 022-23058738 and 022-23058542/43.

What the Numbers Show

The scheduling of the EGM indicates a specific corporate action requiring shareholder consent beyond routine annual matters. The reliance on VC/OAVM reflects ongoing regulatory allowances for virtual meetings, ensuring broader accessibility for geographically dispersed investors. The tight three-day voting window (August 17–19) requires prompt action from shareholders to ensure their votes are recorded before the platform disables on August 19.

Shivalik Rasayan Limited has scheduled an Extra-Ordinary General Meeting (EGM) for Thursday, August 20, 2026, to seek shareholder approval for a preferential allotment worth up to ₹33 crore. The company plans to raise funds through the issuance of equity shares and fully convertible warrants (FCWs) to strengthen its capital base for research and development initiatives in agrochemicals and active pharmaceutical ingredients. This move allows the company to leverage both equity and hybrid instruments while offering investors flexible entry points into its growth trajectory.

The Board of Directors approved the issuance during a meeting held on July 23, 2026. The proposal involves issuing up to 3,72,000 Equity Shares with a face value of ₹5 each at an issue price of ₹250 per share, aggregating to ₹9.30 crore. Simultaneously, the company plans to allot up to 9,48,000 FCWs at the same price point of ₹250 per warrant, totaling ₹23.70 crore. Both instruments are priced in accordance with Chapter V of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and relevant provisions of the Companies Act, 2013.

Equity Share Allotment Details

The equity shares are being offered to public category investors. The allocation is distributed among five entities, primarily involving individual investors and joint holdings. Ashwani Kumar Sharma, a Non-Executive Non-Independent Director of the company, is among the proposed allottees.

Warrant Issuance Structure

The fully convertible warrants are convertible into an equivalent number of equity shares of face value ₹5 each. Holders may convert these warrants in one or more tranches within 18 months from the date of allotment. The allottees include both promoter group entities and public investors. Growel Remedies Limited, controlled by promoter Rahul Bishnoi, is the largest warrant allottee.

Utilization of Proceeds

The company intends to utilize the proceeds primarily for research and development activities related to pharmaceutical products, APIs, and agrochemicals. A significant portion will also be allocated for purchasing analytical equipment and pilot-scale machinery. The remaining funds will be used for general corporate purposes.

Regulatory Approvals and Voting Timeline

The issuance is subject to approval by shareholders and applicable regulatory authorities. The EGM will be held at Hotel Saffron Leaf, Dehradun, Uttarakhand. Shareholders holding shares as on the cut-off date of August 13, 2026, are eligible to vote. Remote e-voting will commence on Monday, August 17, 2026, at 9:00 AM and end on Wednesday, August 19, 2026, at 5:00 PM. Mr. Manoj Kumar Jain, Practicing Company Secretary, has been appointed as the scrutinizer for the voting process. The disclosure was made in compliance with Regulation 30 of the SEBI Listing Regulations, 2015.